APA

Ji S., Park J., You H., Chi H., Bang Y. & Cha S. (20200217). Intact bioactivities and improved pharmacokinetic of the SL335-IFN-β-1a fusion protein that created by genetic fusion of SL335, a human anti-serum albumin fab, and human interferon-β. : Immunology letters.

Chicago

Ji Soo-In, Park Jeong-Ho, You Hyo-Geun, Chi Hyun-Jin, Bang Ye-Won and Cha Sang-Hoon. 20200217. Intact bioactivities and improved pharmacokinetic of the SL335-IFN-β-1a fusion protein that created by genetic fusion of SL335, a human anti-serum albumin fab, and human interferon-β. : Immunology letters.

Harvard

Ji S., Park J., You H., Chi H., Bang Y. and Cha S. (20200217). Intact bioactivities and improved pharmacokinetic of the SL335-IFN-β-1a fusion protein that created by genetic fusion of SL335, a human anti-serum albumin fab, and human interferon-β. : Immunology letters.

MLA

Ji Soo-In, Park Jeong-Ho, You Hyo-Geun, Chi Hyun-Jin, Bang Ye-Won and Cha Sang-Hoon. Intact bioactivities and improved pharmacokinetic of the SL335-IFN-β-1a fusion protein that created by genetic fusion of SL335, a human anti-serum albumin fab, and human interferon-β. : Immunology letters. 20200217.